v3.26.1
Condensed Financial Information of the Parent Company - Schedule of Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 488,248 $ 335,273
Short-term investments 5,483,073 9,613,328
Prepaid expenses and other receivables 17,600 15,721
Total current assets 7,064,498 10,644,515
Equity method investment balance 281,762 278,384
Total assets 8,541,725 12,337,281
Current liabilities    
Accrued expenses and other payables 152,706 156,595
Dividend payable 657,856 212,960
Total current liabilities 1,540,365 1,451,898
Total liabilities 2,145,473 2,043,851
EQUITY    
Common stock 72 72
Additional paid-in capital 550,168 550,168
Accumulated other comprehensive loss (513,252) (707,806)
Retained earnings 2,815,942 6,838,357
Total Sinovac shareholders' equity 4,438,943 8,262,258
Total liabilities and equity 8,541,725 12,337,281
Parent Company    
Current assets    
Cash and cash equivalents 23,908 16,527
Restricted cash 662,894  
Short-term investments 55,270 80,732
Prepaid expenses and other receivables 377 485
Amount due from subsidiaries 20,401 19,350
Dividends receivable 3,616 3,517
Total current assets 766,466 120,611
Equity method investment balance 4,335,737 8,145,953
Total assets 5,102,203 8,266,564
Current liabilities    
Accrued expenses and other payables 5,404 4,306
Dividend payable 657,856  
Total current liabilities 663,260 4,306
Total liabilities 663,260 4,306
EQUITY    
Common stock 72 72
Additional paid-in capital 550,168 550,168
Accumulated other comprehensive loss (513,252) (707,806)
Retained earnings 4,401,955 8,419,824
Total Sinovac shareholders' equity 4,438,943 8,262,258
Total liabilities and equity $ 5,102,203 $ 8,266,564